Journal of General Internal Medicine

, Volume 20, Issue 9, pp 793–799 | Cite as

“Shotgun” versus sequential testing

Cost-effectiveness of diagnostic strategies for vaginitis
  • Phyllis L. Carr
  • Michael B. Rothberg
  • Robert H. Friedman
  • Donna Felsenstein
  • Joseph S. Pliskin
Original Article

Abstract

BACKGROUND: Although vaginitis is a common outpatient problem, only 60% of patients can be diagnosed at the initial office visit of a primary care provider using the office procedures of pH testing, whiff tests, normal saline, and potassium hydroxide preps.

OBJECTIVE: To determine the most cost-effective diagnostic and treatment approach for the medical management of vaginitis.

DESIGN: Decision and cost-effectiveness analyses.

PARTICIPANTS: Healthy women with symptoms of vaginitis undiagnosed after an initial pelvic exam, wet mount preparations, pH, and the four criteria to diagnose bacterial vaginosis.

SETTING: General office practice.

METHODS: We evaluated 28 diagnostic strategies comprised of combinations of pH testing, vaginal cultures for yeast and Trichomonas vaginalis, Gram’s stain for bacterial vaginosis, and DNA probes for Neisseria gonorrhoeae and Chlamydia. Data sources for the study were confined to English language literature.

MEASUREMENT: The outcome measures were symptom-days and costs.

RESULTS: The least expensive strategy was to perform yeast culture, gonorrhoeae and Chlamydia probes at the initial visit, and Gram’s stain and Trichomonas culture only when the vaginal pH exceeded 4.9 ($330, 7.30 symptom days). Other strategies cost $8 to $76 more and increased duration of symptoms by up to 1.3 days. In probabilistic sensitivity analysis, this strategy was always the most effective strategy and was also least expensive 58% of the time.

CONCLUSIONS: For patients with vaginitis symptoms undiagnosed by pelvic examination, wet mount preparations and related office tests, a comprehensive, pH-guided testing strategy at the initial office visit is less expensive and more effective than ordering tests sequentially.

Key Words

vaginitis diagnosis treatment cost-effectiveness decision analysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Paavonen J, Stamm WE. Lower genital tract infections in women. Infect Dis Clin North Am. 1987;1:179.PubMedGoogle Scholar
  2. 2.
    Sparks JM. Vaginitis. J Repro Med. 1991;36:745–52.Google Scholar
  3. 3.
    Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297–301.PubMedGoogle Scholar
  4. 4.
    Schaaf VM, Perez-Stable EJ, Borchardt K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med. 1990;150:1929–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice. JAMA. 1984;251:620–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Carr PL, Thabault P, Levenson S, Friedman RH. Vaginitis in a community based practice. Clin Res. 1992;40:554A.Google Scholar
  7. 7.
    Bleker OP, Folkertsma K, Dirks-Go SIS. Diagnostic procedures in vaginitis. Eur J Obstet Gynec Reprod Biol. 1989;31:179–83.CrossRefGoogle Scholar
  8. 8.
    Eschenbach DA, Hillier SL. Advances in diagnostic testing for vaginitis and cervicitis. J Reprod Med. 1989;34:555–65.PubMedGoogle Scholar
  9. 9.
    Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291:1368–79.PubMedCrossRefGoogle Scholar
  10. 10.
    Sobel JD. Vaginitis in adult women. Obs Gyn Clin N Am. 1990;17:851–79.Google Scholar
  11. 11.
    Sobel JD. Vaginitis. N Engl J Med. 1997;337:1896–1903.PubMedCrossRefGoogle Scholar
  12. 12.
    Holmes KK. Lower genital tract infections in women: cystitis/urethritis vulvovaginitis and cervicitis. In Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually Transmitted Diseases. New York: McGraw-Hill; 1999:527–45.Google Scholar
  13. 13.
    Gratton CA, Lim-fong R, Prasad E, Kibsey PC. Comparison of a DNA probe with culture for detecting Chlamydia trachomatis directly from genital specimens. Mol Cell Probes. 1990;4:25–31.PubMedCrossRefGoogle Scholar
  14. 14.
    Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Am J Obstet Gynecol. 1995;172:1263–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Oral fluconazole for vaginal candidiasis. Med Lett. 1994;36:81–2.Google Scholar
  16. 16.
    Reef SE, Levine WC, McNeil MM, et al. Treatment options for vulvovaginal candidiasis, 1993. Clin Infec. Dis. 1995;20(suppl 1):S80–90.Google Scholar
  17. 17.
    Clark C, Cooper CL, Gordon SF, et al. A multicenter comparison of one-dose tioconazole ointment with three-dose terconazole cream in vulvovaginal candidiasis. J Women’ Health. 1993;2:189–96.Google Scholar
  18. 18.
    Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted disease. MMWR. 1993;42:171.Google Scholar
  19. 19.
    Iwen PC, Blair TM, Woods GL. Comparison of the Gen-Probe PACE 2 system, direct fluorescent-antibody, and cell culture for detecting Chlamydia trachomatis in cervical specimens. Am M Clin Pathol. 1991;95:578–82.Google Scholar
  20. 20.
    Sexually transmitted disease guidelines, CDC. MMWR. 1993;42:171.Google Scholar
  21. 21.
    Bertholf MZ, Stafford MJ. Colonization of Candida albicans in vagina, rectum and mouth. J Fam Pract. 1983;95:919–24.Google Scholar
  22. 22.
    Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiological associations. Am J Med. 1983;74:14–22.PubMedCrossRefGoogle Scholar
  23. 23.
    Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis: comparison of conventional wet mount preparation with cytological studies, cultures and monoclonal antibody staining of direct specimens. JAMA. 1988;259:1223.PubMedCrossRefGoogle Scholar
  24. 24.
    Cotch MF, Pasterek JG, Nugent RP, Yerg DE, Martin DH, Eschenbach DA. Demographics and behavioral predictors of Trichomonas vaginitis infection among pregnant women. Obstet Gynecol. 1991;78:1087–92.PubMedGoogle Scholar
  25. 25.
    Landers DV, Weisenfeld HC, Heine RP, Krohn MA, Hillier SL. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol. 2004;190:1004–10.PubMedCrossRefGoogle Scholar
  26. 26.
    Spiegel SA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol. 1983;18:170–77.PubMedGoogle Scholar
  27. 27.
    Lewis JS, Kranig-Brown D, Trainor DA. DNA probe confirmatory test for Neisseria gonorrhosae. J Clin Microbiol. 1990;28:2349–50.PubMedGoogle Scholar
  28. 28.
    Schwebke JR, Zajackowski ME. Comparison of DNA probe (Gen-Probc) with culture for the detection of Neisseria gonorrhoeae in an urban STD programme. Genitourin Med. 1996;72:108–10.PubMedGoogle Scholar
  29. 29.
    Granato PA, Franz MR. Evaluation of a prototype DNA probe test for the noncultural diagnosis of gonorrhea. J Clin Microbiol. 1989;27:632–5.PubMedGoogle Scholar
  30. 30.
    Szell A, Tisza T, Horvath A. A comparative study for detection of Chlamydia trachomatis and Neisseria gonorrhoeae with DNA probe. Acta Microbiol Immunol Hung. 1994;41:291–3.PubMedGoogle Scholar
  31. 31.
    Loeffelholz MJ, Lewinski CA, Silver SR, et al. Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J Clin Microbiol. 1992;30:2847–51.PubMedGoogle Scholar
  32. 32.
    Lees MI, Newman DM, Garland SM. Comparison of a DNA probe assay with culture for the detection of Chlamydia trachomatis. J Med Microbiol. 1991;35:159–61.PubMedCrossRefGoogle Scholar
  33. 33.
    Mercer LJ, Robinson DC, Sahm DF, Lawrie MJ, Hajj SN. Comparison of chemiluminescent NA probe to cell culture for the screening of Chlamydia trachomatis in a gynecology clinic population. Obstet Gynecol. 1990;76:114–7.PubMedGoogle Scholar
  34. 34.
    U.S. Bureau of Labor Statistics. Employer Cost for Employee Compensation. Accessed December 2, 2003 (http://www.bls.gov/ncs/ect/home.htm#data).Google Scholar
  35. 35.
    Bloom BS, Wierz DJ, Pauly MV. Cost and price of comparable branded and generic pharmaceuticals. JAMA. 1986;256:2523–30.PubMedCrossRefGoogle Scholar
  36. 36.
    1993 Red Book. Montvale, NJ: Medical Economics Data Inc; 1993.Google Scholar
  37. 37.
    Edelson JT, Weinstein MC, Tosteson ANA, et al. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:407–13.PubMedCrossRefGoogle Scholar
  38. 38.
    Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1986;302:1109–17.CrossRefGoogle Scholar
  39. 39.
    Thibault GE. Diagnostic strategy—the shotgun versus the arrow. N Engl J Med. 1995;332:321–5.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2005

Authors and Affiliations

  • Phyllis L. Carr
    • 1
  • Michael B. Rothberg
    • 2
    • 3
  • Robert H. Friedman
    • 1
  • Donna Felsenstein
    • 4
  • Joseph S. Pliskin
    • 5
  1. 1.Department of MedicineBoston University School of MedicineBostonUSA
  2. 2.Division of General Medicine and Geriatrics, Department of MedicineBaystate Medical CenterBostonUSA
  3. 3.Tuffs University School of MedicineBostonUSA
  4. 4.Division of Infectious Disease, Massachusetts General HospitalHarvard Medical SchoolBostonUSA
  5. 5.Departments of Industrial Engineering and Management, and Health Systems ManagementBen Gurion University of the NegevBeer ShevaIsrael

Personalised recommendations